TSCAN THERAPEUTICS INC COM is a security (CUSIP 89854M101) tracked across SEC portfolio filings. 60 institutional managers reported $31.5M on Form 13F as of 2026-06-30; 8 registered fund positions totaling $2.1M via N-PORT as of 2026-03-31.
Showing 15 of 60 managers by value.
| Manager | Location | Value | Shares |
|---|---|---|---|
| Lynx1 Capital Management LP | SAN JUAN, PR | $8.1M | 8,019,148 |
| BVF INC/IL | San Francisco, CA | $5.6M | 5,564,290 |
| BAKER BROS. ADVISORS LP | NEW YORK, NY | $2.8M | 2,784,792 |
| VANGUARD GROUP INC | Valley Forge, PA | $2.5M | 2,475,733 |
| BlackRock, Inc. | New York, NY | $1.9M | 1,840,952 |
| MILLENNIUM MANAGEMENT LLC | NEW YORK, NY | $1.5M | 1,460,285 |
| RENAISSANCE TECHNOLOGIES LLC | NEW YORK, NY | $1.4M | 1,364,783 |
| Deer Management Co. LLC | Larchmont, NY | $1.3M | 1,245,504 |
| TWO SIGMA INVESTMENTS, LP | New York, NY | $1.2M | 1,209,009 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | FLORHAM PARK, NJ | $816K | 808,356 |
| DC Funds, LP | MCLEAN, VA | $630K | 630,000 |
| GEODE CAPITAL MANAGEMENT, LLC | BOSTON, MA | $623K | 616,952 |
| D. E. Shaw & Co., Inc. | New York, NY | $323K | 319,587 |
| CITADEL ADVISORS LLC | MIAMI, FL | $322K | 318,411 |
| MARSHALL WACE, LLP | LONDON, X0 | $240K | 237,346 |
| Fund | Registrant | Value | % of fund |
|---|---|---|---|
| abrdn Life Sciences Investors | abrdn Life Sciences Investors | $845K | 15.07% |
| VANGUARD EXTENDED MARKET INDEX FUND | VANGUARD INDEX FUNDS | $583K | 0.07% |
| BlackRock Health Sciences Term Trust | BlackRock Health Sciences Term Trust | $411K | 4.06% |
| abrdn Healthcare Investors | abrdn Healthcare Investors | $120K | 1.05% |
| BlackRock Health Sciences Trust | BlackRock Health Sciences Trust | $49K | 0.92% |
| VANGUARD BALANCED INDEX FUND | VANGUARD VALLEY FORGE FUNDS | $47K | 0.01% |
| VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND | VANGUARD INSTITUTIONAL INDEX FUNDS | $30K | 0.01% |
| Blackstone Alternative Multi-Strategy Fund | Blackstone Alternative Investment Funds | $7K | 0.02% |